Roflumilast reduces allergen-induced airway inflammation in patients with asthma
Healio “The studies presented here show that roflumilast has no acute bronchodilator actions in patients with mild to moderate asthma,” Philip Bardin, PhD, the director of the lung and sleep unit at Monash Health in Australia, and colleagues wrote. “This … |
View full post on asthma – Google News